Tailored Antiplatelet Initiation to Lesson Outcomes Due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention (TAILOR-PCI)
Latest Information Update: 13 Nov 2021
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Myocardial infarction; Stent thrombosis; Stroke; Thrombosis
- Focus Therapeutic Use
- Acronyms TAILOR-PCI
- 11 Oct 2021 Number of treatment arms has been decreased from 2 to 4, by the removal of Active Comparator: Clopidogrel then Retrospective Genotyping arm and Experimental: Digital Sub-Study arm. One more primary end-point has been added for safety.
- 07 Aug 2021 Status changed from active, no longer recruiting to completed.
- 14 Jun 2021 Planned End Date changed from 30 Jun 2021 to 30 Jul 2021.